Andrew H. Lipsky, Jay N. Lozier, Adrian Wiestner. Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. haematol [Internet]. 2016Feb.29 [cited 2024Apr.28];101(3):e124-e125. Available from: https://haematologica.org/article/view/7665